PedAM
Pediatric Disease Annotations & Medicines
| Disease | primary myelofibrosis |
| Phenotype | C0026986|myelodysplastic syndrome |
| Sentences | 10 |
| PubMedID- 22937321 | A diagnosis of myelodysplastic syndrome (mds) with myelofibrosis was rendered. |
| PubMedID- 22781796 | Objective: to analyze the clinical features and prognosis of the primary myelodysplastic syndrome with myelofibrosis (mds-mf) patients and to improve the cognition of mds-mf. |
| PubMedID- 24186132 | bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems. |
| PubMedID- 23660629 | The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes. |
| PubMedID- 23457485 | Exclusion criteria were prior chronic renal dysfunction, previously treated malignancy (>4 weeks after the first chemotherapy dose), relapsing or refractory hematological malignancy, bone marrow or stem cell transplantation, low-grade or chronic malignancy (chronic myelogenous leukemia, chronic lymphocytic leukemia, low-grade nhl, multiple myeloma, myelodysplastic syndrome, myelofibrosis with myeloid metaplasia, or aplastic anemia), and absence of potentially lifespan-extending treatment options. |
| PubMedID- 21282718 | myelodysplastic syndromes with bone marrow fibrosis. |
| PubMedID- 24809010 | Hematologic improvements in a myelodysplastic syndromes with myelofibrosis (mds-f) patient treated with azacitidine. |
| PubMedID- 20971823 | Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis. |
| PubMedID- 23882429 | An exceptional case of myelodysplastic syndrome with myelofibrosis following combination chemotherapy for squamous cell lung cancer. |
| PubMedID- 26171043 | Primary myelodysplastic syndrome (mds) with myelofibrosis is a rare hematological disorder that should be classified as a distinct subgroup of mds. |
Page: 1